Location and function of VPAC1, VPAC2 and NPR-C receptors in VIP-induced vasodilation of porcine basilar arteries

被引:33
|
作者
Grant, S
Lutz, EM
McPhaden, AR
Wadsworth, RM
机构
[1] Univ Strathclyde, Dept Physiol & Pharmacol, Glasgow G4 0NR, Lanark, Scotland
[2] Univ Strathclyde, Dept Biosci, Glasgow G4 0NR, Lanark, Scotland
[3] Glasgow Royal Infirm, Dept Pathol, Glasgow G4 0SF, Lanark, Scotland
来源
关键词
NPR-C receptor; vasoactive intestinal peptide; VPAC receptors;
D O I
10.1038/sj.jcbfm.9600163
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vasoactive intestinal peptide (VIP) is a vasodilator peptide present in cerebrovascular nerves. Vasoactive intestinal peptide can activate VPAC(1), VPAC(2) and the NPR-C receptor. This study sought to determine the receptors involved in VIP-induced vasodilation of porcine basilar arteries. Porcine basilar arteries contained the messenger ribonucleic acid of all three receptors. Immunocytochemical analysis of porcine basilar arteries revealed that the VPAC(1) receptor is expressed on the endothelium, VPAC(2) on the outer layers of the media and the NPR-C receptor throughout the artery, including nerves. Vasodilator responses to all receptor agonists showed that the receptors are functional. The vasodilator response to the VPAC(1) receptor agonist was inhibited by L-NAME and abolished by endothelial denudation. Vasodilation induced by Ro-25-1553, the VPAC(2) agonist, was unaffected by NOS inhibition or removal of the endothelium. Activation of the NPR-C receptor produced a vasodilation, which was susceptible to NOS inhibition and independent of endothelium. The vasodilator response to electrical stimulation at 20 Hz was attenuated by PG-99-465, the VPAC(2) antagonist. This study shows that all known VIP receptors are involved in VIP-mediated vasodilation of porcine basilar arteries. The VPAC(1) receptor is located on the endothelium and elicits vasodilation by generating nitric oxide (NO). The VPAC(2) receptor is mainly expressed in the outer layers of the smooth muscle and induces vasodilation independently of NO in response to VIP released from intramural nerves. The NPR-C receptor produces NO-dependent vasodilation independently of the endothelium by stimulation of nNOS in intramural nerves.
引用
收藏
页码:58 / 67
页数:10
相关论文
共 33 条
  • [1] THE EXPRESSION OF VIP RECEPTORS, VPAC1 AND VPAC2, IS RELATED TO DISEASE ACTIVITY IN PATIENTS WITH EARLY ARTHRITIS
    Ortiz, A. M.
    Piris, L.
    Gonzalez-Alvaro, I.
    Seoane, I. V.
    Lamana, A.
    Juarranz, Y.
    Leceta, J.
    Gomariz, R. P.
    Martinez, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 839 - 839
  • [2] Evidence for the involvement of VPAC1 and VPAC2 receptors in pressure-induced vasodilatation in rodents
    Fizanne, L
    Sigaudo-Roussel, D
    Saumet, JL
    Fromy, B
    JOURNAL OF PHYSIOLOGY-LONDON, 2004, 554 (02): : 519 - 528
  • [3] In Silico Classification and Prediction of VIP Derivatives as VPAC1/VPAC2 Receptor Agonists/Antagonists
    Li, Jiazhong
    Wang, Xin
    Liu, Huanxiang
    Li, Hongyu
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2015, 18 (01) : 33 - 41
  • [4] Internalization and trafficking of the VIP receptors:: A comparison between the recombinant VPAC1 and VPAC2 human receptors expressed in cho cells
    Langlet, C
    Gaspard, N
    Vertongen, P
    Robberecht, P
    Langer, I
    REGULATORY PEPTIDES, 2004, 122 (01) : 26 - 26
  • [5] Role of VPAC1 and VPAC2 receptors in the etiology of pregnancy rhinitis: an experimental study in rats
    Ulkumen, Burak
    Batir, Muhammet Burak
    Ulkumen, Burcu Artunc
    Pala, Halil Gursoy
    Vatansever, Seda
    Cam, Sirri
    BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, 2022, 88 (04) : 505 - 510
  • [6] Elucidation of the VIP pharmacophore for human VPAC1 and VPAC2 and development of simplified VIP analogs with receptor selectivity and stability
    Igarashi, Hisato
    Ito, Tetsuhide
    Yoshinaga, Masahiro
    Sakai, Hironori
    Muto, Yoichi
    Takayanagi, Ryoichi
    Coy, David H.
    Jensen, Robert T.
    REGULATORY PEPTIDES, 2006, 135 (03) : 131 - 131
  • [7] Alanine-scanning of VIP and molecular modeling of VIP analogs: Determination of important residues for interaction with human VPAC1 and VPAC2 receptors
    Laburthe, M
    Nicole, P
    Rouyer-Fessard, C
    Couvineau, A
    Maoret, JJ
    Drouot, C
    Fulcrand, P
    Martinez, J
    Lins, L
    Thomas, A
    Brasseur, R
    GASTROENTEROLOGY, 1999, 116 (04) : A621 - A621
  • [8] VIP enhances synaptic transmission to hippocampal CA1 pyramidal cells through activation of both VPAC1 and VPAC2 receptors
    Cunha-Reis, D
    Ribeiro, JA
    Sebastiao, AM
    REGULATORY PEPTIDES, 2005, 130 (03) : 159 - 160
  • [9] VPAC2 receptors mediate VIP-induced neuroprotection against neonatal excitotoxic brain lesions in mice
    Rangon, CM
    Goursaud, S
    Medja, F
    Leliévre, V
    Mounien, L
    Husson, I
    Brabet, P
    Jégou, S
    Janet, T
    Gressens, P
    REGULATORY PEPTIDES, 2005, 130 (03) : 150 - 150
  • [10] Elucidation of the vasoactive intestinal peptide pharmacophore for VPAC2 receptors in human and rat and comparison to the pharmacophore for VPAC1 receptors
    Igarashi, H
    Ito, T
    Pradhan, TK
    Mantey, SA
    Hou, W
    Coy, DH
    Jensen, RT
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (02): : 445 - 460